Pamoate
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21384 publications
Efficacy and tolerability of co-administration of clozapine with atypical antipsychotics in patients with treatment-resistant schizophrenia, comorbid with chemical addictions
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: October 20, 2026
In vitro in-depth characterization of emodepside in combination with key anthelmintic drugs on soil-transmitted helminths.
Journal: Antimicrobial agents and chemotherapy
Published: October 08, 2026
Is there a difference in ovarian hyperstimulation syndrome rates in freeze-all treatment cycles in high-risk patients treated with different GnRH agonist triggers?
Journal: Human fertility (Cambridge, England)
Published: October 05, 2026
Concurrent use of two long-acting injectable (LAI) antipsychotics in forensic patients with treatment-resistant schizophrenia: A case series.
Journal: Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists
Published: September 30, 2026
Olanzapine-Induced Rapid Weight Gain and Metabolic Disorders: A Case Series.
Journal: Psychopharmacology bulletin
Published: September 20, 2026
Characterising the pharmacokinetics of olanzapine in patients with anorexia nervosa (TORPEDO): protocol for a multicentre cross-sectional study.
Journal: BMJ open
Published: September 15, 2026
Olanzapine for the Prevention and Treatment of ICU Delirium: Protocol for a Systematic Review With Meta-Analysis.
Journal: Acta anaesthesiologica Scandinavica
Published: August 21, 2026
Liquid chromatography-tandem mass spectrometry quantification of five antihistamines in antemortem blood: method validation and application.
Journal: Journal of analytical toxicology
Published: August 13, 2026
Comparative Risk of Hyponatremia Among Patients Treated With Second-Generation Antipsychotics.
Journal: JAMA network open
Published: August 13, 2026
Dexamethasone-Free Antiemetic Prophylaxis for Children and Adolescents Receiving Highly Emetogenic Chemotherapy: A Multicenter, Phase III, Noninferiority Trial (CIVIC POD).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 31, 2026
A 12-week study on the effects of betahistine (an H₃ antagonist/H₁ agonist) on cognitive functions in schizophrenia patients treated with olanzapine.
Journal: Experimental and clinical psychopharmacology
Published: July 23, 2026
Last Updated: 11/08/2026